How can we differentiate supratentorial tumor recurrence from postradiation imaging changes in children treated for primary malignant brain tumors?

被引:1
作者
Zittoun, Jacob [1 ]
Dangouloff-Ros, Volodia [1 ,3 ,4 ]
Cardoen, Liesbeth [5 ]
Rutten, Caroline [1 ]
Bolle, Stephanie [6 ]
Alapetite, Claire [8 ]
Levy, Raphael [1 ,3 ,4 ]
Grevent, David [1 ,3 ,4 ]
Grill, Jacques [7 ]
Brisse, Herve J. [5 ]
Doz, Francois [9 ]
Blauwblomme, Thomas [2 ]
Beccaria, Kevin [2 ]
Charpy, Sarah [1 ,3 ,4 ,10 ,12 ]
Roux, Charles-Joris [1 ,3 ,4 ]
Varlet, Pascale [11 ]
Dufour, Christelle
Puget, Stephanie [2 ]
Boddaert, Nathalie [1 ,3 ,4 ]
机构
[1] Hop Necker Enfants Malad, AP HP, Dept Pediat Radiol, Paris, France
[2] Hop Necker Enfants Malad, AP HP, Dept Pediat Neurosurg, Paris, France
[3] Imagine Inst, UMR 1163, Paris, France
[4] Paris Cite Univ, INSERM, UA1299, Paris, France
[5] Curie Inst, Dept Radiol, Paris, France
[6] Gustave Roussy Inst, Dept Radiat Therapy, Villejuif, France
[7] Gustave Roussy Inst, Dept Pediat & Adolescent Oncol, Villejuif, France
[8] Curie Inst, Proton Ctr, Dept Radiat Oncol, Paris, France
[9] Curie Inst, Oncol Ctr SIREDO Care Innovat & Res Children Adole, Paris, France
[10] Paris Saclay Univ, Ecole Normale Super, Paris, France
[11] St Anne Hosp, GHU Paris Psychiat & Neurosci, Dept Neuropathol, Paris, France
[12] Hop Necker Enfants Malad, AP HP, Paris, France
关键词
radiation treatment effect; brain tumor; recurrence; pediatric; MRI; oncology; CEREBRAL RADIATION NECROSIS; HIGH-DOSE CHEMOTHERAPY; WHITE-MATTER LESIONS; PEDIATRIC-PATIENTS; PSEUDOPROGRESSION; THERAPY; RADIOTHERAPY; PROGRESSION; CHILDHOOD; DISEASE;
D O I
10.3171/2023.3.PEDS22386
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE Distinguishing tumor recurrence from therapy-induced imaging changes (TIIC) on brain MRI in children treated for primary malignant brain tumors may be challenging. The authors aimed to assess the diagnostic ability of multimodal MRI in differentiating TIIC from tumor recurrence.METHODS The authors retrospectively included children with abnormal supratentorial brain MRI findings after treat- ment for primary malignant brain tumors (regardless of their localization) with complete resection and radiotherapy. A total of 18 patients with TIIC and 25 patients with tumor recurrence were compared, according to structural, apparent diffusion coefficient (ADC), and arterial spin labeling (ASL) imaging data accrued over time. TIIC were defined by a new MRI scan that was stable for at least 1 year or had regressed, or by histopathology findings in specimens obtained when the anomaly was surgically treated.RESULTS The time interval between completion of radiotherapy and the appearance of abnormal brain MRI findings was significantly shorter in the TIIC group compared with the tumor recurrence group (median 6 vs 35 months; p < 0.001). TIIC appeared as foci of increased T2-weighted signal intensity, without nodule, associated with variable contrast enhancement. Tumor recurrence appeared as a well-defined nodule with intermediate signal intensity on T2-weighted images with nodular contrast enhancement. Relative ADC values were significantly higher in the TIIC group (median 1.43 vs 0.88; p < 0.001). Relative ASL-cerebral blood flow (CBF) values were significantly lower in the TIIC group (me- dian 0.27 vs 0.43; p = 0.04). On follow-up MRI, TIIC could progress, regress, or remain stable. In most instances (72%), they decreased in size or remained stable at 4 years of follow-up.CONCLUSIONS MRI features of TIIC include foci of increased signal intensity without a demonstrable nodule on T2 weighted images, high ADC values, and lower ASL-CBF values, whereas tumor recurrence appears as a well-defined nodule with low ADC values and higher ASL-CBF values.
引用
收藏
页码:173 / 183
页数:11
相关论文
共 7 条
  • [1] Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression?
    Walker, Amanda J.
    Ruzevick, Jake
    Malayeri, Ashkan A.
    Rigamonti, Daniele
    Lim, Michael
    Redmond, Kristin J.
    Kleinberg, Lawrence
    FUTURE ONCOLOGY, 2014, 10 (07) : 1277 - 1297
  • [2] Imaging Changes in Very Young Children with Brain Tumors Treated with Proton Therapy and Chemotherapy
    Sabin, N. D.
    Merchant, T. E.
    Harreld, J. H.
    Patay, Z.
    Klimo, P.
    Qaddoumi, I.
    Armstrong, G. T.
    Wright, K.
    Gray, J.
    Indelicato, D. J.
    Gajjar, A.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2013, 34 (02) : 446 - 450
  • [3] Brain FET PET tumor-to-white mater ratio to differentiate recurrence from post-treatment changes in high-grade gliomas
    Puranik, Ameya D.
    Rangarajan, Venkatesh
    Dev, Indraja D.
    Jain, Yash
    Purandare, Nilendu C.
    Sahu, Arpita
    Choudhary, Amitkumar
    Gupta, Tejpal
    Chatterjee, Abhishek
    Moiyadi, Aliasgar
    Shetty, Prakash
    Sridhar, Epari
    Sahay, Ayushi
    Patil, Vijay M.
    Shah, Sneha
    Agrawal, Archi
    JOURNAL OF NEUROIMAGING, 2021, 31 (06) : 1211 - 1218
  • [4] Soft tissue masses with myxoid stroma: Can conventional magnetic resonance imaging differentiate benign from malignant tumors?
    Crombe, A.
    Alberti, N.
    Stoeckle, E.
    Brouste, V.
    Buy, X.
    Coindre, J-M.
    Kind, M.
    EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (10) : 1875 - 1882
  • [5] Perfusion Weighted MR Imaging may Differentiate Primary CNS Lymphoma from other Homogeneously Enhancing Brain Tumors
    Abul-Kasim, K.
    Maly, P.
    Strombeck, A.
    Svensson, J.
    Sundgren, P. C.
    NEURORADIOLOGY JOURNAL, 2008, 21 (05) : 637 - 644
  • [6] Hybrid 18F-FET PET and Perfusion MRI to Differentiate Disease Progression from Treatment-Related Changes in Malignant Brain Tumors
    Galldiks, Norbert
    Langen, Karl-Josef
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (07) : 1093 - 1094
  • [7] Tumor-Promoted Changes in Pediatric Brain Histology Can Be Distinguished from Normal Parenchyma by Desorption Electrospray Ionization Mass Spectrometry Imaging
    Seidinger, Ana L.
    Silva, Felipe L. T.
    Euzebio, Mayara F.
    Krieger, Anna C.
    Meidanis, Joao
    Gutierrez, Junier M.
    Bezerra, Thais M. S.
    Queiroz, Luciano
    Silva, Alex A. Rosini.
    Hoffmann, Iva L.
    Daiggi, Camila M. M.
    Tedeschi, Helder
    Eberlin, Marcos N.
    Eberlin, Livia S.
    Yunes, Jose A.
    Porcari, Andreia M.
    Cardinalli, Izilda A.
    BIOMEDICINES, 2024, 12 (11)